How did CME's R&D expenses evolve since 2022?

CME Group's Research and Development (R&D) expenses have shown a positive trend, increasing from $188.6 million in 2022 to $218.7 million in 2023. This indicates a growing commitment to innovation and improvement in their products and services.

|code|Ticker|Name|Date|R&D Expenses|R&D Expenses YoY|market_code|
|---|---|---|---|---|---|---|
|CME|CME.O|CME Group|2022 Q1|4.59E7|-4.771784232365145|185|
|CME|CME.O|CME Group|2022 Q2|4.59E7|-6.896551724137931|185|
|CME|CME.O|CME Group|2022 Q3|4.68E7|-5.070993914807302|185|
|CME|CME.O|CME Group|2022 Q4|5.0E7|9.170305676855897|185|

|code|Ticker|Name|Date|R&D Expenses|R&D Expenses YoY|market_code|
|---|---|---|---|---|---|---|
|CME|CME.O|CME Group|2023 Q1|5.13E7|11.76470588235294|185|
|CME|CME.O|CME Group|2023 Q2|5.33E7|16.122004357298476|185|
|CME|CME.O|CME Group|2023 Q3|5.56E7|18.803418803418804|185|
|CME|CME.O|CME Group|2023 Q4|5.85E7|17|185|